Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors
A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors
2014
Leora Horn
G. Blumenscheine
Heather A. Wakelee
T.H. Arkenau
Gary Dukart
Kimberly Harrow
Chris Liang
Jay Gibbons
Christine M. Lovly
Jeffrey R. Infante
Keywords:
ALK inhibitor
Pathology
Medicine
Internal medicine
Radiology
in patient
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]